Key to biosimilar competition will come from interchangeability, FDA officials say
With the growth in biologics spending, the biosimilar market is going to have to find new ways to keep up.
One avenue may open up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
